Ugrás a tartalomra
Merck

HIL2-RO

Roche

Interleukin-2, human (hIL-2)

recombinant (E. coli)

Bejelentkezésa Szervezeti és Szerződéses árazás megtekintéséhez


About This Item

UNSPSC kód:
12352202

biológiai forrás

human

Minőségi szint

rekombináns

expressed in E. coli

Teszt

95% (SDS-PAGE)

Forma

solution

hatékonyság

>2 x 10^6 units/mg EC50

molekulatömeg

(15,000 Da)

kiszerelés

pkg of 10,000 U (10799068001 [5 μg, 50 ml])
pkg of 10,000 U (11011456001 [5 μg, 1 ml])
pkg of 50,000 U (11147528001 [25 μg, 5 ml])

gyártó/kereskedő neve

Roche

tárolási körülmény

avoid repeated freeze/thaw cycles

koncentráció

10-20U/ml

szennyeződések

<0.1 EU/μg

UniProt elérési szám

tárolási hőmérséklet

−20°C

Géninformáció

human ... IL2(3558)

Általános leírás

Recombinant Interleukin-2, human (hIL-2) is produced in E. coli and purified by standard chromatographic techniques. Solution in PBS and 1 mg/ml BSA, filtered through a 0.2 μm pore size membrane.

Egyediség

Species specificity: Recombinant IL-2, human is effective on mouse and human cells.

Alkalmazás

Recombinant IL-2, human, allows:
  • The cultivation of human and murine IL-2 dependent T-cell lines and natural killer cell lines.
  • The proliferation of mitogen-activated T-lymphocytes and natural killer cells.
  • The establishment of human and murine thymocyte, splenocyte, or peripheral blood lymphocyte (PBL) derived T-cell lines.
  • The generation of human and murine lymphokine-activated killer (LAK) cells (1-11).
  • In vitro re-stimulation of lung cells obtained from mice.

Biokémiai/fiziológiai hatások

Interlekin-2 (IL-2) is a potent pro-inflammatory cytokine. It plays a protective role in autoimmune chronic inflammation, when present in low amounts. It is involved in maintaining immune homeostasis where it controls the cross-talk between T regulatory and T effector cells. Studies in acute myelogenous leukemia (AML) mice models show that antibody based delivery of IL-2 to targets present in tumor-linked vasculature results in antileukemic activity.

Minőség

Purity: >95% pure as determined by SDS-PAGE
Endotoxin level: <0.1 EU/μg (LAL-test), <10 EU/ml (LAL-test)
(1 EU corresponds to 0.1 ng)

Szekvencia

Chain Length 134 AA
The primary structure of recombinant, IL-2, human is identical to that of natural, human IL-2 (one polypeptide chain, 133 amino acids), however, recombinant IL-2 has an extra methionine at the amino-terminus (one polypeptide chain, 134 amino acids) and is not glycosylated. Glycosylation is not essential for biological activity.

Egység definíció

EC50 definition: The amount of hIL-2 that is required to support half-maximal stimulation of cell proliferation (XTT cleavage) with CTLL-2 cells (1 unit equals ≤0.5 ng).

Unit Conversion: 1 BM unit = 3.25 NBSB units (natural IL-2)

Fizikai forma

Solution in PBS and 1 mg/ml BSA, filtered through a 0.2 μm pore size membrane

Elkészítési megjegyzés

Working concentration: 10 -20 U/ml
Established IL-2-dependent T-cell lines usually require 10-20 U/ml. Add IL-2 to the freezing medium for IL-2 dependent cell lines.

Working solution: Dilute the concentrated IL-2 solution (200 U/ml or 10,000 U/ml) with PBS or culture medium containing 1 mg/ml BSA or HSA (0.1%) or 1 to 10% serum.

Storage conditions (working solution): -15 to -25 °C
It is recommended to store the solution in aliquots at -15 to -25 °C.
Note: Avoid repeated freezing and thawing.

Specific activity/EC 50 : >2 x 106 U/mg <0.5 ng/ml (hIL-2, NIBSC, 1st international standard, 86/504), at least the same specific activity (EC50 ) compared to the indicated standard is guaranteed (19, 20). Human, recombinant IL-2 has the same biological activity in vitro as compared to human, natural IL-2 (15, 1–4).

Recommended Method of Dilution: Dilute the concentrated IL-2 solution (200 U/ml or 10,000 U/ml) with PBS or culture medium containing 1 mg/ml BSA or HSA (0.1%) or 1–10% serum.
Interleukin-2 (IL-2, also known as T-Cell Growth Factor, TCGF) is a lymphokine which is produced by lectin- or antigen-activated T-cells and plays an important immunoregulatory role. This factor, or lymphokine, was first identified by its ability to promote the long-term in vitro proliferation of activated T cells. It also promotes the generation and proliferation of cytotoxic T-cells, natural killer (NK) cells, and lymphokine- activated killer (LAK) cells (1–11). Recombinant human IL-2 allows the cultivation of human and murine IL-2-dependent T-cell lines and natural killer cell lines, the proliferation of mitogenactivated T-lymphocytes and natural killer cells, the establishment of human and murine thymocyte-, splenocyte-, or peripheral blood lymphocyte (PBL)- derived T-cell lines, and the generation of human and murine lymphokine-activated killer (LAK) cells (1-11). Established IL-2-dependant T-cell lines usually require 10-20 U/ml. Add IL-2 to the freezing medium for IL-2 dependant cell lines.

Egyéb megjegyzések

For life science research only. Not for use in diagnostic procedures.

gyakran vásárolják ezzel a termékkel együtt

Product No.
Leírás
Árazás

Tárolási osztály kódja

12 - Non Combustible Liquids

WGK

nwg

Lobbanási pont (F)

No data available

Lobbanási pont (C)

No data available


Válasszon a legfrissebb verziók közül:

Analitikai tanúsítványok (COA)

Lot/Batch Number

Nem találja a megfelelő verziót?

Ha egy adott verzióra van szüksége, a tétel- vagy cikkszám alapján rákereshet egy adott tanúsítványra.

Már rendelkezik ezzel a termékkel?

Az Ön által nemrégiben megvásárolt termékekre vonatkozó dokumentumokat a Dokumentumtárban találja.

Dokumentumtár megtekintése

Az ügyfelek ezeket is megtekintették

Marcel A Schijf et al.
Journal of virology, 86(21), 11472-11482 (2012-08-17)
Breast feeding reduces the risk of developing severe respiratory syncytial virus (RSV) infections in infants. In addition to maternal antibodies, other immune-modulating factors in human milk contribute to this protection. Specific dietary prebiotic oligosaccharides, similar to oligosaccharides present in human
Christoph Schliemann et al.
Cancer immunology research, 3(5), 547-556 (2015-02-13)
The antibody-based delivery of IL2 to extracellular targets expressed in the easily accessible tumor-associated vasculature has shown potent antileukemic activity in xenograft and immunocompetent murine models of acute myelogenous leukemia (AML), especially in combination with cytarabine. Here, we report our
Elisa Lupino et al.
Immunology, 131(2), 231-241 (2010-05-15)
Stimulation of naïve CD4(+) T cells through engagement of the T-cell receptor (TCR) and the CD28 co-receptor initiates cell proliferation which critically depends on interleukin (IL)-2 secretion and subsequent autocrine signalling via the IL-2 receptor. However, several studies indicate that
Agata Kosmaczewska
International journal of molecular sciences, 15(10), 18574-18592 (2014-10-17)
For many years, the role of interleukin-2 (IL-2) in autoimmune responses was established as a cytokine possessing strong pro-inflammatory activity. Studies of the past few years have changed our knowledge on IL-2 in autoimmune chronic inflammation, suggesting its protective role
Beibei Wu et al.
eLife, 10 (2021-12-16)
CRAC channel regulator 2 A (CRACR2A) is a large Rab GTPase that is expressed abundantly in T cells and acts as a signal transmitter between T cell receptor stimulation and activation of the Ca2+-NFAT and JNK-AP1 pathways. CRACR2A has been

Tudóscsoportunk valamennyi kutatási területen rendelkezik tapasztalattal, beleértve az élettudományt, az anyagtudományt, a kémiai szintézist, a kromatográfiát, az analitikát és még sok más területet.

Lépjen kapcsolatba a szaktanácsadással